Drug reference

maribavir

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 831

Overview

Names and pronunciation

Increlex

PDF page 831

Functional class

Func. class.: Antiviral-kinase inhibitor

PDF page 831

Uses

USES: Posttransplant CMV infection/ disease

PDF page 831

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES • Adult/child: SUBCUT ≥12 yr and older, ≥35 kg: 400 mg (2 tablets) bid

PDF page 831

Available forms

Available forms: Tabs 200 mg

PDF page 831

Dose text by age group

Adult/child

• Adult/child: SUBCUT ≥12 yr and older, ≥35 kg: 400 mg (2 tablets) bid

PDF page 831

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

maribavir

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 831

Overview

Names and pronunciation

Increlex

PDF page 831

Functional class

Func. class.: Antiviral-kinase inhibitor

PDF page 831

Uses

USES: Posttransplant CMV infection/ disease

PDF page 831

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES • Adult/child: SUBCUT ≥12 yr and older, ≥35 kg: 400 mg (2 tablets) bid

PDF page 831

Available forms

Available forms: Tabs 200 mg

PDF page 831

Dose text by age group

Adult/child

• Adult/child: SUBCUT ≥12 yr and older, ≥35 kg: 400 mg (2 tablets) bid

PDF page 831

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.